Effects of Dietary Palm Olein on the Cardiovascular Risk Factors in Healthy Young Adults

Overview

Journal Food Nutr Res

Specialty Nutritional Sciences

Date 2018 Jul 25

PMID 30038554

Citations 6

Authors

Chenyan Lv

Yifei Wang

Cui Zhou

Weiwei Ma

Yuexin Yang

Rong Xiao

Huanling Yu

Affiliations

Soon will be listed here.

Abstract

Background: Dietary saturated fatty acids are always being hotly debated. Palm olein rich in saturated fatty acids (45.98%) is often considered as being atherogenic nutritionally. There is a lack of information on effects of dietary oil by partially replacing with palm olein on human health.

Methods: A randomized controlled trial with 88 participants has been conducted to elucidate the effect of palm olein on cardiovascular risk factors.

Results: By comparing the soybean oil group (saturated fatty acids amounted to 23.31%) with the cocoa butter group (saturated fatty acids amounted to 93.76%), no significant difference was found ( > 0.05) in physiological parameters, serum oxidative stress levels, inflammatory factor, glucose metabolism, and lipid profiles of subjects, which are all cardiovascular risk factors. Although results showed that intervention time can influence the cardiovascular risk factors significantly ( < 0.05), there is no relationship between intervention time and dietary oil type.

Conclusion: Therefore, partial replacement of dietary oil by palm olein may not affect cardiovascular risk factors in healthy young adults. There are differences between our research and previous researches, which may be due to the different amount of palm olien in diet. Our research will provide a solid foundation for the application of palm olein in human diets and in the food industry.

Citing Articles

Safety and efficacy of oil palm phenolic supplementation in improving lipid profile among hyperlipidemic adults: a phase 2, randomized, double-blind, placebo-controlled clinical trial.

Muhammad Ismail Tadj N, Ibrahim N, Tg Abu Bakar Sidik T, Zulfarina M, Haji Mohd Saad Q, Leow S Front Pharmacol. 2023; 14:1190663.

PMID: 37484009 PMC: 10360129. DOI: 10.3389/fphar.2023.1190663.

Effects of Dietary Linoleic Acid on Blood Lipid Profiles: A Systematic Review and Meta-Analysis of 40 Randomized Controlled Trials.

Wang Q, Zhang H, Jin Q, Wang X Foods. 2023; 12(11).

PMID: 37297374 PMC: 10253160. DOI: 10.3390/foods12112129.

Balancing functional and health benefits of food products formulated with palm oil as oil sources.

Sulaiman N, Sintang M, Mantihal S, Zaini H, Munsu E, Mamat H Heliyon. 2022; 8(10):e11041.

PMID: 36303903 PMC: 9593283. DOI: 10.1016/j.heliyon.2022.e11041.

Impact of Replacement of Individual Dietary SFAs on Circulating Lipids and Other Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Humans.

Sellem L, Flourakis M, Jackson K, Joris P, Lumley J, Lohner S Adv Nutr. 2021; 13(4):1200-1225.

PMID: 34849532 PMC: 9340975. DOI: 10.1093/advances/nmab143.

Hypocholesterolaemic and Anti-Atherogenic Effects of Palm-Based Oils (NoveLin I and NoveLin II) in Cholesterol-Fed Rabbits.

Idris C, Lin S, Razis A Int J Environ Res Public Health. 2020; 17(9).

PMID: 32384714 PMC: 7246421. DOI: 10.3390/ijerph17093226.

References

Filippou A, Teng K, Berry S, Sanders T . Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women. Eur J Clin Nutr. 2014; 68(9):1036-41. PMC: 4155797. DOI: 10.1038/ejcn.2014.141. View

Micha R, Mozaffarian D . Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010; 45(10):893-905. PMC: 2950931. DOI: 10.1007/s11745-010-3393-4. View

Bayorh M, Abukhalaf I, Ganafa A . Effect of palm oil on blood pressure, endothelial function and oxidative stress. Asia Pac J Clin Nutr. 2005; 14(4):325-39. View

Weihua Mmed L, Yougang W, Jing W . Reduced or modified dietary fat for preventing cardiovascular disease. J Cardiovasc Nurs. 2013; 28(3):204-5. DOI: 10.1097/JCN.0b013e3182816005. View

Lucci P, Borrero M, Ruiz A, Pacetti D, Frega N, Diez O . Palm oil and cardiovascular disease: a randomized trial of the effects of hybrid palm oil supplementation on human plasma lipid patterns. Food Funct. 2015; 7(1):347-54. DOI: 10.1039/c5fo01083g. View

Zock P, de Vries J, de Fouw N, Katan M . Positional distribution of fatty acids in dietary triglycerides: effects on fasting blood lipoprotein concentrations in humans. Am J Clin Nutr. 1995; 61(1):48-55. DOI: 10.1093/ajcn/61.1.48. View

Sanders T, Filippou A, Berry S, Baumgartner S, Mensink R . Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr. 2011; 94(6):1433-41. DOI: 10.3945/ajcn.111.017459. View

Calder P . Functional Roles of Fatty Acids and Their Effects on Human Health. JPEN J Parenter Enteral Nutr. 2015; 39(1 Suppl):18S-32S. DOI: 10.1177/0148607115595980. View

San Mauro Martin I, Collado Yurrita L, Cuadrado Cenzual M, Cabanas M, Mendive Dubourdieu P . Role of ApoA1 on high-density lipoprotein: an intervention with plant sterols in patients with hypercholesterolemia. Nutr Hosp. 2015; 31(1):494-9. DOI: 10.3305/nh.2015.31.1.8147. View

10.

Voon P, Ng T, Lee V, Nesaretnam K . Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr. 2011; 94(6):1451-7. DOI: 10.3945/ajcn.111.020107. View

11.

Budin S, Othman F, Louis S, Bakar M, Das S, Mohamed J . The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao Paulo). 2009; 64(3):235-44. PMC: 2666447. DOI: 10.1590/s1807-59322009000300015. View

12.

Keys A, Anderson J, Grande F . Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. Metabolism. 2014; 14(7):776-87. DOI: 10.1016/0026-0495(65)90004-1. View

13.

Huebbe P, Dose J, Schloesser A, Campbell G, Gluer C, Gupta Y . Apolipoprotein E (APOE) genotype regulates body weight and fatty acid utilization-Studies in gene-targeted replacement mice. Mol Nutr Food Res. 2014; 59(2):334-43. DOI: 10.1002/mnfr.201400636. View

14.

Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen J . Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. J Lipid Res. 1995; 36(6):1370-84. View

15.

Praagman J, Beulens J, Alssema M, Zock P, Wanders A, Sluijs I . The association between dietary saturated fatty acids and ischemic heart disease depends on the type and source of fatty acid in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Am J Clin Nutr. 2016; 103(2):356-65. DOI: 10.3945/ajcn.115.122671. View

16.

Valsta L, Tapanainen H, Sundvall J, Laatikainen T, Mannisto S, Pietinen P . Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr. 2010; 13(6A):932-8. DOI: 10.1017/S1368980010001126. View

17.

Wei M, Jacobson T . Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep. 2011; 13(6):474-83. DOI: 10.1007/s11883-011-0210-3. View

18.

Farsi P, Djazayery A, Eshraghian M, Koohdani F, Saboor-Yaraghi A, Derakhshanian H . Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients. Arq Bras Endocrinol Metabol. 2014; 58(4):335-40. DOI: 10.1590/0004-2730000002861. View

19.

Jakobsen M, OReilly E, Heitmann B, Pereira M, Balter K, Fraser G . Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009; 89(5):1425-32. PMC: 2676998. DOI: 10.3945/ajcn.2008.27124. View

20.

Matthan N, Welty F, Barrett P, Harausz C, Dolnikowski G, Parks J . Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004; 24(6):1092-7. DOI: 10.1161/01.ATV.0000128410.23161.be. View